陈竺实验室平均每人不到0.3篇论文， 每篇耗资数百万

新语丝上有人为陈竺喊冤，说他论文多。水平高。

陈竺花了几亿美元，没一篇自然、科学论文，国内年轻人，发自然、科学的很多了。

喊冤的人列了陈竺101篇论文，把综述、合作的，都列上去了。他的综述，都在国内杂志，有少数在国外很差的杂志，没有一篇综述在国际上中游杂志。所以，不算。他导师王振义的论文，他老婆的论文，也不能算。只算他自己实验室的，101就成了28篇。

十七年28篇，平均每年不到两篇，他实验室这十七年有过一百三十多人，平均每人不到0.3篇。

他这十七年，实验室用了4亿人民币，平均每篇多少钱？

水平呢？

陈竺论文发表的杂志，SCI分数在3左右。

最好的，是PNAS。他没当院士以前，他的PNAS都是谈家祯给通讯进去。他当院士以后，自己通讯进去。全是后门，不能算。

有本身，自己发一篇自然。不要开后门。

不要说，没钱，没人，哦。

4: Philos Trans R Soc Lond B Biol Sci. 2007 Jun
29;362(1482):959-71.
Treatment of acute promyelocytic leukaemia with
all-trans retinoic acid and
arsenic trioxide: a paradigm of synergistic molecular
targeting therapy.
Zhou GB, Zhang J, Wang ZY, Chen SJ, Chen Z.
6: Blood. 2007 Apr 15;109(8):3441-50. Epub 2006 Dec
29.
Oridonin, a diterpenoid extracted from medicinal
herbs, targets AML1-ETO fusion
protein and shows potent antitumor activity with low
adverse effects on t(8;21)
leukemia in vitro and in vivo.
Zhou GB, Kang H, Wang L, Gao L, Liu P, Xie J, Zhang
FX, Weng XQ, Shen ZX, Chen J,
Gu LJ, Yan M, Zhang DE, Chen SJ, Wang ZY, Chen Z.
17: J Biol Chem. 2005 Oct 21;280(42):35261-71. Epub
2005 Aug 22.
Identification and characterization of a novel human
histone H3 lysine
36-specific methyltransferase.
Sun XJ, Wei J, Wu XY, Hu M, Wang L, Wang HH, Zhang QH,
Chen SJ, Huang QH, Chen Z.
23: PLoS Med. 2005 Jan;2(1):e12.
Retinoic acid and arsenic for treating acute
promyelocytic leukemia.
Zhou GB, Zhao WL, Wang ZY, Chen SJ, Chen Z.
Shanghai Institute of Hematology and State Key
Laboratory for Medical Genomics,
Rui Jin Hospital, Shanghai Second Medical University,
Shanghai, China.
30: Blood. 2004 Dec 15;104(13):4219-25. Epub 2004 Aug
31.
Combined effects of As4S4 and imatinib on chronic
myeloid leukemia cells and
BCR-ABL oncoprotein.
Yin T, Wu YL, Sun HP, Sun GL, Du YZ, Wang KK, Zhang J,
Chen GQ, Chen SJ, Chen Z.
33: Proc Natl Acad Sci U S A. 2004 Apr
13;101(15):5328-35. Epub 2004 Mar 24.
All-trans retinoic acid/As2O3 combination yields a
high quality remission and
survival in newly diagnosed acute promyelocytic
leukemia.
Shen ZX, Shi ZZ, Fang J, Gu BW, Li JM, Zhu YM, Shi JY,
Zheng PZ, Yan H, Liu YF,
Chen Y, Shen Y, Wu W, Tang W, Waxman S, De Th茅 H,
Wang ZY, Chen SJ, Chen Z.
48: Hematol J. 2000;1(3):206-17.
Gene expression in CD34(+) cells from normal bone
marrow and leukemic origins.
Gu J, Zhang QH, Huang QH, Ren SX, Wu XY, Ye M, Huang
CH, Fu G, Zhou J, Niu C, Han
ZG, Chen SJ, Chen Z.
53: Leukemia. 2001 Sep;15(9):1359-68.
Molecular cytogenetic characterization and clinical
relevance of additional,
complex and/or variant chromosome abnormalities in
acute promyelocytic leukemia.
Xu L, Zhao WL, Xiong SM, Su XY, Zhao M, Wang C, Gao
YR, Niu C, Cao Q, Gu BW, Zhu
YM, Gu J, Hu J, Yan H, Shen ZX, Chen Z, Chen SJ.
54: Leukemia. 2001 May;15(5):735-41.
Studies on the clinical efficacy and pharmacokinetics
of low-dose arsenic
trioxide in the treatment of relapsed acute
promyelocytic leukemia: a comparison
with conventional dosage.
Shen Y, Shen ZX, Yan H, Chen J, Zeng XY, Li JM, Li XS,
Wu W, Xiong SM, Zhao WL,
Tang W, Wu F, Liu YF, Niu C, Wang ZY, Chen SJ, Chen Z.
55: Chin Med J (Engl). 1998 Dec;111(12):1107-10.
Pharmacokinetics of intravenous arsenic trioxide in
the treatment of acute
promyelocytic leukemia.
Ni J, Chen G, Shen Z, Li X, Liu H, Huang Y, Fang Z,
Chen S, Wang Z, Chen Z.
Department of Immunogenetics, Shanghai Institute of
Transfusion, Shanghai Blood
Centre, Shanghai, 200051, China.
57: Genome Res. 2000 Oct;10(10):1546-60.
Cloning and functional analysis of cDNAs with open
reading frames for 300
previously undefined genes expressed in CD34+
hematopoietic stem/progenitor
cells.
Zhang QH, Ye M, Wu XY, Ren SX, Zhao M, Zhao CJ, Fu G,
Shen Y, Fan HY, Lu G, Zhong
M, Xu XR, Han ZG, Zhang JW, Tao J, Huang QH, Zhou J,
Hu GX, Gu J, Chen SJ, Chen
Z.
59: Blood. 2000 Aug 15;96(4):1496-504.
Gene expression networks underlying retinoic
acid-induced differentiation of
acute promyelocytic leukemia cells.
Liu TX, Zhang JW, Tao J, Zhang RB, Zhang QH, Zhao CJ,
Tong JH, Lanotte M, Waxman
S, Chen SJ, Mao M, Hu GX, Zhu L, Chen Z.
61: Int J Hematol. 1999 Dec;70(4):248-60.
Long-term survival and prognostic study in acute
promyelocytic leukemia treated
with all-trans-retinoic acid, chemotherapy, and As2O3:
an experience of 120
patients at a single institution.
Hu J, Shen ZX, Sun GL, Chen SJ, Wang ZY, Chen Z.
63: J Biol Chem. 1999 Dec 10;274(50):35741-8.
Molecular cloning of six novel Kruppel-like zinc
finger genes from hematopoietic
cells and identification of a novel transregulatory
domain KRNB.
Han ZG, Zhang QH, Ye M, Kan LX, Gu BW, He KL, Shi SL,
Zhou J, Fu G, Mao M, Chen
SJ, Yu L, Chen Z.
69: Proc Natl Acad Sci U S A. 1998 Jul
7;95(14):8175-80.
Identification of genes expressed in human CD34(+)
hematopoietic stem/progenitor
cells by expressed sequence tags and efficient
full-length cDNA cloning.
Mao M, Fu G, Wu JS, Zhang QH, Zhou J, Kan LX, Huang
QH, He KL, Gu BW, Han ZG,
Shen Y, Gu J, Yu YP, Xu SH, Wang YX, Chen SJ, Chen Z.
73: Blood. 1997 May 1;89(9):3345-53.
Use of arsenic trioxide (As2O3) in the treatment of
acute promyelocytic leukemia
(APL): I. As2O3 exerts dose-dependent dual effects on
APL cells.
Chen GQ, Shi XG, Tang W, Xiong SM, Zhu J, Cai X, Han
ZG, Ni JH, Shi GY, Jia PM,
Liu MM, He KL, Niu C, Ma J, Zhang P, Zhang TD, Paul P,
Naoe T, Kitamura K, Miller
W, Waxman S, Wang ZY, de The H, Chen SJ, Chen Z.
74: Leukemia. 1997 Apr;11(4):609-11.
A case of acute eosinophilic granulocytic leukemia
with PML-RAR alpha fusion gene
expression and response to all-trans retinoic acid.
Yu RQ, Huang W, Chen SJ, Jiang SD, Chen Z.
76: J Mol Cell Cardiol. 1996 Sep;28(9):1879-83.
Identification of a novel missense mutation in the
cardiac beta-myosin heavy
chain gene in a Chinese patient with sporadic
hypertrophic cardiomyopathy.
Kuang SQ, Yu JD, Lu L, He LM, Gong LS, Chen SJ, Chen
Z.
77: Blood. 1996 Aug 1;88(3):1052-61.
In vitro studies on cellular and molecular mechanisms
of arsenic trioxide (As2O3)
in the treatment of acute promyelocytic leukemia:
As2O3 induces NB4 cell
apoptosis with downregulation of Bcl-2 expression and
modulation of PML-RAR
alpha/PML proteins.
Chen GQ, Zhu J, Shi XG, Ni JH, Zhong HJ, Si GY, Jin
XL, Tang W, Li XS, Xong SM,
Shen ZX, Sun GL, Ma J, Zhang P, Zhang TD, Gazin C,
Naoe T, Chen SJ, Wang ZY, Chen
Z.
78: Cancer Genet Cytogenet. 1996 Jun;88(2):110-7.
Long-term follow-up of minimal residual disease in
childhood acute lymphoblastic
leukemia patients by polymerase chain reaction
analysis of multiple
clone-specific or malignancy-specific gene markers.
Kuang S, Gu L, Dong S, Cao Q, Xu C, Huang W, Su XY,
Huang QH, Xie JX, Chen SJ,
Chen Z.
81: Genes Chromosomes Cancer. 1996 Mar;15(3):147-56.
Retinoic acid regulatory pathways, chromosomal
translocations, and acute
promyelocytic leukemia.
Chen Z, Tong JH, Dong S, Zhu J, Wang ZY, Chen SJ.
83: Cancer Genet Cytogenet. 1995 May;81(1):76-82.
RT/PCR detection of SIL-TAL-1 fusion mRNA in Chinese
T-cell acute lymphoblastic
leukemia (T-ALL).
Huang W, Kuang SQ, Huang QH, Dong S, Zhang T, Gu LJ,
Ching LM, Chen SJ, Chang LC,
Chen Z.
84: Leukemia. 1995 Feb;9(2):302-9.
Effect of retinoic acid isomers on proliferation,
differentiation and PML
relocalization in the APL cell line NB4.
Zhu J, Shi XG, Chu HY, Tong JH, Wang ZY, Naoe T,
Waxman S, Chen SJ, Chen Z.
87: C R Acad Sci III. 1994 Dec;317(12):1135-41.
Retinoic acid and acute promyelocytic leukemia: a
model of targetting treatment
for human cancer.
Chen Z, Chen SJ, Wang ZY.
88: Leukemia. 1994 May;8(5):729-34.
AML-1 gene rearrangement and AML-1-ETO gene expression
as molecular markers of
acute myeloblastic leukemia with t(8;21).
Zhang T, Hillion J, Tong JH, Cao Q, Chen SJ, Berger R,
Chen Z.
89: Proc Natl Acad Sci U S A. 1994 Feb
1;91(3):1178-82.
PLZF-RAR alpha fusion proteins generated from the
variant t(11;17)(q23;q21)
translocation in acute promyelocytic leukemia inhibit
ligand-dependent
transactivation of wild-type retinoic acid receptors.
Chen Z, Guidez F, Rousselot P, Agadir A, Chen SJ, Wang
ZY, Degos L, Zelent A,
Waxman S, Chomienne C.
93: J Clin Invest. 1993 May;91(5):2260-7.
Rearrangements of the retinoic acid receptor alpha and
promyelocytic leukemia
zinc finger genes resulting from t(11;17)(q23;q21) in
a patient with acute
promyelocytic leukemia.
Chen SJ, Zelent A, Tong JH, Yu HQ, Wang ZY, Derr J,
Berger R, Waxman S, Chen Z.
94: EMBO J. 1993 Mar;12(3):1161-7.
Fusion between a novel Kruppel-like zinc finger gene
and the retinoic acid
receptor-alpha locus due to a variant t(11;17)
translocation associated with
acute promyelocytic leukaemia.
Chen Z, Brand NJ, Chen A, Chen SJ, Tong JH, Wang ZY,
Waxman S, Zelent A.
101: Leukemia. 1991 Apr;5(4):288-92.
The retinoic acid alpha receptor gene is frequently
disrupted in its 5' part in
Chinese patients with acute promyelocytic leukemia.
Chen Z, Chen SJ, Tong JH, Zhu YJ, Huang ME, Wang WC,
Wu Y, Sun GL, Wan